These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Inhibition of cadmium teratogenesis by a mercaptoacrylic acid (MFA). Ferm VH; Hanlon DP Experientia; 1987 Feb; 43(2):208-10. PubMed ID: 3817107 [TBL] [Abstract][Full Text] [Related]
24. The effect of cadmium on placental structure and its relation to fetal malformations in the mouse. Padmanabhan R Z Mikrosk Anat Forsch; 1986; 100(3):419-27. PubMed ID: 3765785 [No Abstract] [Full Text] [Related]
25. Effect of natural teratogens in poisonous plants on fetal development in domestic animals. Keeler RF Adv Exp Med Biol; 1972; 27():107-25. PubMed ID: 4681679 [No Abstract] [Full Text] [Related]
26. Developmental abnormalities induced by 6-mercaptopurine in the hamster. Shah RM; Burdett DN Can J Physiol Pharmacol; 1979 Jan; 57(1):53-8. PubMed ID: 427645 [TBL] [Abstract][Full Text] [Related]
27. Retinoids as teratogens. Soprano DR; Soprano KJ Annu Rev Nutr; 1995; 15():111-32. PubMed ID: 8527214 [TBL] [Abstract][Full Text] [Related]
28. Mutagenic and carcinogenic N-nitroso compounds: possible environmental hazards. Montesano R; Bartsch H Mutat Res; 1976; 32(3-4):179-228. PubMed ID: 785242 [No Abstract] [Full Text] [Related]
29. [Teratogens during pregnancy]. Jancárková N; Gregor V Ceska Gynekol; 2000 May; 65(3):188-94. PubMed ID: 10953498 [TBL] [Abstract][Full Text] [Related]
30. Predictive value of minor anomalies: II. Use in cohort studies to identify teratogens. Holmes LB; Kleiner BC; Leppig KA; Cann CI; Muñoz A; Polk BF Teratology; 1987 Dec; 36(3):291-7. PubMed ID: 3424217 [TBL] [Abstract][Full Text] [Related]
31. Teratogenic interaction of hyperthermia and vitamin A. Ferm VH; Ferm RR Biol Neonate; 1979; 36(3-4):168-72. PubMed ID: 486606 [TBL] [Abstract][Full Text] [Related]
32. Lupin alkaloids from teratogenic and nonteratogenic lupins. III. Identification of anagyrine as the probable teratogen by feeding trials. Keeler RF J Toxicol Environ Health; 1976 Jul; 1(6):887-98. PubMed ID: 966318 [TBL] [Abstract][Full Text] [Related]
33. Human teratogens: delineating the phenotypic effects, the period of greatest sensitivity, the dose-response relationship and mechanisms of action. Holmes LB Prog Clin Biol Res; 1988; 281():177-91. PubMed ID: 3174711 [No Abstract] [Full Text] [Related]
34. [Function of maternal immune-system and the embryonic sensitivity to teratogens]. Fein A; Torchinsky A; Toder V Harefuah; 1998 Feb; 134(3):198-200. PubMed ID: 9662912 [No Abstract] [Full Text] [Related]
35. Birth defect surveillance in the search for and evaluation of possible human teratogens. Oakley GP J Environ Pathol Toxicol; 1978; 2(1):211-6. PubMed ID: 722223 [No Abstract] [Full Text] [Related]
37. Teratology Society position paper: recommendations for vitamin A use during pregnancy. Teratology; 1987 Apr; 35(2):269-75. PubMed ID: 3603408 [No Abstract] [Full Text] [Related]
38. The new teratogens: accutane and other vitamin-A analogs. Thomson EJ; Cordero JF MCN Am J Matern Child Nurs; 1989; 14(4):244-8. PubMed ID: 2501615 [No Abstract] [Full Text] [Related]
39. Developmental toxicity of ribavirin/IFalpha combination therapy: is the label more dangerous than the drugs? Polifka JE; Friedman JM Birth Defects Res A Clin Mol Teratol; 2003 Jan; 67(1):8-12. PubMed ID: 12749379 [No Abstract] [Full Text] [Related]
40. [Effect of drug substances on the embryo and fetus]. Kudrin AN; Babkina TA; Pashin IuV Akush Ginekol (Mosk); 1978 Nov; (11):52-7. PubMed ID: 727394 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]